Related by context. All words. (Click for frequent words.) 73 Oral Fingolimod 72 Shows Promise Against 71 Patients Treated With 71 Antitumor Activity 71 Combination REOLYSIN R 71 Mouse Model 71 Mouse Models 70 Prolongs Survival 70 Adjuvant Chemotherapy 70 Hormone Refractory Prostate Cancer 70 Relapsed Refractory 70 Initiates Clinical Trial 70 Improves Survival 70 Preclinical Study 70 Adjuvant Treatment 70 Drug Shows Promise 69 Leukemias 69 Inhibits 69 Progenitor Cells 69 Improves Outcomes 69 Receives Orphan Drug Designation 69 CYT# potent vascular disrupting 69 HER2 Positive 69 Immune Responses 69 Completes Patient Enrollment 69 sarcoma melanoma 69 Endothelial Cells 69 Metastases 69 Refractory Hodgkin Lymphoma 69 Treatment Shows Promise 69 Breast Cancer Cells 69 Appears Safe 69 Novel Oral 68 Chronic HCV 68 Study Evaluating 68 Squamous 68 Bone Metastases 68 Phase 2b Clinical Trial 68 Shows Promising 68 Lowers Risk 68 Meets Primary Endpoint 68 Endometrial 68 Novel Treatments 68 essential thrombocythemia ET 68 Slow Progression 68 Kinase Inhibitor 68 Adenoma 68 metastatic pancreatic 68 Factor Receptor 68 metastatic gastric 68 Proves Effective 68 Investigational Treatment 68 HER2 Positive Breast Cancer 68 Cutaneous T 68 Antigen Specific 68 Trial Evaluating 68 Drug Candidate 68 Previously Treated 68 TNF Blockers 68 Naive Patients 67 Advanced Melanoma 67 Therapeutic Efficacy 67 Chronic Hepatitis C 67 Files IND 67 Soft Tissue Sarcoma 67 Hsp# Inhibitor 67 Liver Tumors 67 Pharmacokinetics PK 67 Renal Cell Carcinoma 67 Clinical Trial Evaluating 67 Patients Receiving 67 Node Positive 67 Metastatic Melanoma 67 LHRH receptor positive 67 Cell Transplants 67 Lung Tumors 67 Hepatocellular Carcinoma 67 Slows Progression 67 Circulating Tumor Cells 67 Shows Efficacy 67 Allogeneic 67 Pooled Analysis 67 Adenoviral 67 Anti Tumor Activity 67 Vaccine Shows Promise 67 Parathyroid Hormone 67 Patients Undergoing 67 Clinical Trial Results 67 Vaccine Adjuvant 67 Advanced Colorectal Cancer 67 Achieves Primary Endpoint 67 Malignant Melanoma 67 Metastatic Renal Cell Carcinoma 67 Dendritic Cells 67 Initiates Phase II 67 Advanced Renal Cell 67 Protein Linked 67 Gene Mutation 67 Complicated Skin 67 Prednisone Against Refractory 67 ErbB2 positive 67 Hepatocellular 67 Helps Diagnose 67 Effectively Treats 66 Unresectable 66 Prostate Tumors 66 B Cell Lymphoma 66 Relapsing Multiple Sclerosis 66 refractory chronic lymphocytic 66 Metastatic Prostate Cancer 66 Successfully Treats 66 Tumor Response 66 Gastric Cancer 66 Modulates 66 Tyrosine Kinase Inhibitor 66 Basal Cell 66 FDA Okays 66 Levels Linked 66 Genes Identified 66 Randomized Phase II 66 stage IIIb IV 66 Long Term Efficacy 66 Successfully Completes Phase 66 Mimetics 66 bone marrow reticulin deposition 66 Metastatic Colorectal Cancer 66 resistant hormone refractory 66 Presents Preclinical Data 66 Phase 2a Clinical Trial 66 R lenalidomide 66 Hematology Molecular Pathology 66 Phase IIa Clinical Trial 66 Epidermal Growth Factor Receptor 66 Cerebrospinal Fluid 66 Initiate Clinical Trial 66 Newly Diagnosed Multiple Myeloma 66 paclitaxel cisplatin 66 Prostatic 66 FDA Clears 66 Preclinical Data 66 Gene Linked 66 Oncolytic Reovirus 66 Attenuates 66 tumors GIST 66 Hemodialysis Patients 66 Remission Maintenance 66 Breast Cancer Recurrence 66 CYP#A# CYP#D# 66 Vidaza ® 66 Disease Modifying 66 Drug Prevents 66 Cancer Cells 66 Reduces Mortality 66 sunitinib Sutent ® 66 Initiate Phase 66 Knee Osteoarthritis 66 Is Well Tolerated 66 FDA Approves Drug 66 Patients Suffering 66 Dose Ranging Study 66 Severe Sepsis 66 Transdermal Patch 66 Aflibercept 66 Intravitreal 66 Improved Survival 66 Randomized Double blind 65 Genes Predict 65 Carcinomas 65 Successfully Treated 65 Randomized Phase 65 Genes Linked 65 II Clinical Trial 65 pralatrexate injection folate analogue 65 TO AVOID PREGNANCY WHILE 65 myelodysplastic myeloproliferative diseases 65 Lupus Nephritis 65 tumor xenograft models 65 Peginterferon Alfa 2a 65 Completes Enrollment 65 Virus Linked 65 Test Detects 65 PEGylated Fab fragment 65 Cancer Incidence Mortality 65 Inflammatory Diseases 65 Hormone Receptor Positive 65 dasatinib Sprycel ® 65 Atypical Hemolytic Uremic Syndrome 65 R Saizen R 65 J Clin 65 Myelofibrosis 65 Anthracycline 65 Adjuvant Therapy 65 Vaccine Prevents 65 Systemic Sclerosis 65 chronic eosinophilic leukemia 65 Prospective Randomized 65 Polymerase Inhibitor 65 Gene Variants 65 Aurora Kinase 65 Breast Cancers 65 Postmenopausal Women 65 Romidepsin 65 Inflammatory Markers 65 INSPIRE Trial Phase III 65 GVAX Immunotherapy 65 metastatic colorectal 65 Hypertrophy 65 Pharmacokinetic Study 65 Myelodysplastic Syndromes 65 Pancreas Cancer 65 K ras mutations 65 FOLFOX6 chemotherapy regimen 65 Phase IIb Trial 65 Degarelix 65 Castration Resistant Prostate Cancer 65 Acute Exacerbations 65 erlotinib Tarceva ® 65 Preclinical Models 65 Monoclonal Antibody 65 Tumor Growth 65 Adjunctive Therapy 65 TRAIL R1 65 Demonstrates Potential 65 Kidney Transplant Patients 64 Kinase Inhibitors 64 Brain Metastases 64 Advanced Prostate Cancer 64 CTAP# Capsules 64 Genes Involved 64 Phase IIb Clinical Trial 64 Transplant Rejection 64 Treated Patients 64 Glucocorticoid 64 Previously Untreated 64 novel VDA molecule 64 Peripheral Blood 64 Lenalidomide 64 Elderly Patients 64 Controlled Study 64 metastatic colorectal carcinoma 64 Anti Tumor 64 Orally Active 64 Commences Phase 64 Demonstrates Efficacy 64 Demonstrates Significant 64 Randomized Double Blind 64 Prostate Cancer Progression 64 Drug Combo 64 Tyrosine Kinase Inhibitors 64 FUSILEV enhances 64 ® lenalidomide 64 Predict Response 64 ATRA IV 64 Dose Escalation 64 Lymphocytic 64 Diabetic Foot Ulcer 64 Philadelphia Chromosome Positive 64 Tissue Engineered 64 Alimentary Tract 64 Gene Mutations 64 Autoantibodies 64 Diffuse Large B 64 Immunotherapeutic 64 Aggressive Prostate Cancer 64 Colorectal Adenomas 64 Novel Inhibitor 64 Subtypes 64 Regenerative Cell 64 Genetic Predisposition 64 Endocrinol 64 Myeloid 64 Survival Benefit 64 Sangamo BioSciences Announces 64 Granted Orphan Drug 64 Anthrax Toxin 64 Advanced Solid Tumors 64 Humanized Anti 64 Diabetic Neuropathy 64 bladder ovarian 64 Researchers Identify 64 Treatment Naïve Patients 64 Drug Resistant 64 Papillomavirus 64 LymphoStat B belimumab 64 non resectable metastatic 64 ORLive Presents 64 Phase 2b Study 64 Heart Failure Patients 64 Randomized Study 64 Amgen Neulasta R 64 Treatment Reduces 64 soluble tumor necrosis 64 Initiates Enrollment 64 Recombinant Human 64 Invasive Breast Cancer 64 metastatic malignant 64 Vaccine Protects Against 64 Suppl. 64 Prove Effective 64 MKC# MT 64 Minimally Invasive Procedure 64 colorectal carcinoma 64 interferon beta 1a infertility 64 Melphalan 64 kidney urologic 64 Chronic Lymphocytic Leukemia CLL 64 Hypertensive Patients 64 Significantly Improves 64 Ribavirin causes 64 Mg Usa 64 Antiviral Therapy 64 Aortic Valve 64 Immune Cells 64 Pivotal Phase 64 AVI BioPharma Announces 64 Diagnostic Tests 64 Pediatric Patients 64 Small Intestine 64 Phase 2a Trial 64 Radiofrequency Ablation 64 Treating Chronic 64 demonstrated antitumor activity 64 Recurrent Breast Cancer 64 Collaborators Present 64 Patients Treated 63 Maven Semantic 63 Multiple Sclerosis Rheumatoid Arthritis 63 MGd 63 syngeneic 63 Induces Apoptosis 63 Spectrum Pharmaceuticals Announces 63 Renal Cancer 63 NASH Huntington 63 Chronic Sinusitis 63 Therapy Improves 63 Gene Variant 63 TNF Tumor Necrosis Factor 63 Heterozygous Familial Hypercholesterolemia 63 Parathyroid 63 Demonstrated Significant 63 Proc Am Soc 63 Xeloda ® 63 Soluble CD# 63 Contrast Agent 63 Omacetaxine 63 Sipuleucel T 63 Insulin Glargine 63 Genetic Variation 63 Obesity Linked 63 Combination Treatment 63 Dose Finding 63 recurrent NSCLC 63 pulmonary metastases 63 IIa Clinical Trial 63 ThermoDox R 63 hyaluronidase enzyme 63 Carcinoma 63 Treatment Naive Patients 63 PRN FDA Approves 63 Vascular Disrupting Agent 63 dependent kinase inhibitor 63 carcinoma mCRC 63 hip osteonecrosis avascular 63 Lung Cancer Patients 63 Initiates Phase 2b 63 Mg Uk 63 Plaque Psoriasis 63 accumulate preferentially 63 Acute Renal Failure 63 Cervical Dysplasia 63 Phase #b/#a clinical 63 Announces FDA Clearance 63 Clinical Outcome 63 sorafenib tablets 63 Paclitaxel Eluting 63 Autologous Stem Cell Transplantation 63 advanced hepatocellular carcinoma 63 Breast Tumors 63 Initiates Phase 63 Malignancies 63 Bosutinib 63 Anticancer Activity 63 Signaling Pathway 63 Suppresses 63 gastrointestinal stromal 63 West Nile Syphilis 63 vapreotide acetate 63 castration resistant hormone refractory 63 Phase 2b Trial 63 papillary renal cell carcinoma 63 Sapacitabine 63 Epithelial 63 Improve Survival 63 Predict Risk 63 Chronic Renal Failure 63 Glioblastoma Multiforme 63 Liver Metastases 63 Squamous Cell Carcinoma 63 Bayer HealthCare Onyx Pharmaceuticals 63 humanized therapeutic 63 Personalized Immunotherapy 63 deCODE ProstateCancer TM 63 advanced metastatic renal 63 Androgen Deprivation Therapy 63 Study Shows Promise 63 Epstein Barr Virus EBV 63 Pivotal Clinical Trial 63 Presents Positive 63 Tumor Targeting 63 Chronic Hepatitis B 63 Antisense Oligonucleotides 63 Antiviral Activity 63 VEGFR2 inhibitor 63 5 fluorouracil leucovorin 63 Therapeutic Targets 63 cell carcinoma RCC 63 Protease Inhibitors 63 Chronic Myeloid Leukemia 63 Kidney Transplant Recipients 63 Colon Polyps 63 Telaprevir VX 63 trastuzumab Herceptin R 63 Immunomodulatory 63 Crit Rev 63 Cancer Patients Treated 63 Lymphoid 63 Chemotherapy Improves 63 Non Invasive Treatment 63 Systemic Delivery 63 Arterial Disease 63 RhuDex R 63 Mucosal 63 mitoxantrone plus 63 Sustained Efficacy 63 Anticancer Drugs 63 complement inhibitor eculizumab 63 Inhaled Corticosteroids 63 Contrast Agents 63 R roscovitine CDK cyclin 63 Investigational Oral 63 candidates Azedra TM 63 Chemokine Receptor 63 Targeted Therapy 63 Platinol ® 63 lexidronam injection 63 Renal Impairment 63 Tezampanel 63 Bone Marrow Transplants 63 Myeloma Patients 63 Immunogenicity 62 Diabetic Nephropathy 62 chemotherapy cisplatin 62 Rheumatoid Arthritis Patients 62 brivanib 62 Gene Mutation Linked 62 Reports Preclinical Data 62 fallopian tube cancers 62 FDA Approvals 62 Pivotal Trial 62 Genes Discovered 62 AAG geldanamycin analog 62 AnaSpec Introduces 62 Antibody Drug Conjugate 62 Chronic Myelogenous Leukemia 62 Glufosfamide 62 Relapsed Refractory Multiple Myeloma 62 Antitumor 62 Lung Cancer Survival 62 Initiates Dosing 62 Poorly Controlled 62 metastatic GIST 62 Antithrombin 62 metastatic ocular 62 Brentuximab Vedotin SGN 62 Pivotal Study 62 Carboplatin Paclitaxel 62 Begins Dosing 62 Reperfusion Injury 62 Safinamide 62 Eur J 62 acetonide FA 62 Oral Calcitonin 62 Dose Escalation Study 62 platform HDL Mimetic 62 intravesical infusion therapy 62 Study Demonstrates 62 Gene Variation 62 Seliciclib CYC# 62 Daclizumab 62 Polyneuropathy 62 orally administered inhibitor 62 Immunomedics Announces 62 protein tyrosine phosphatase 1B 62 Epratuzumab 62 Endometrial Cancer 62 Cell Non Hodgkin 62 Cell Lymphoma 62 Gastrointestinal Tract 62 Prostate Cancer Patients 62 recurrent metastatic ovarian cancer 62 Demonstrates Positive 62 Advanced Ovarian Cancer 62 Study Shows Benefits 62 alpha folate receptor 62 Thiazolidinediones 62 Initiates Phase III 62 HDAC Inhibitor 62 Skeletal Muscle 62 IND Application 62 cisplatin gemcitabine 62 FOLFOX6 62 HCV Protease Inhibitor 62 Increased Risk 62 Gastrointestinal Stromal Tumors 62 Ovarian Cancer Patients 62 Septic Shock 62 Fungal Infections 62 Could Detect 62 TRIOLEX HE# APOPTONE HE# 62 Human Monoclonal Antibody 62 alfa 2a 62 refractory metastatic 62 metastatic neuroendocrine tumors 62 Beneficial Effects 62 Lobular 62 Estrogen Receptor 62 Tumor Suppressor Gene 62 5 FU leucovorin 62 Glioma 62 investigational oral inhibitor 62 REMINDER ORLive Presents 62 Enlarged Prostate 62 Subgroup Analysis 62 J Am Acad 62 vinorelbine tartrate 62 Localized Prostate Cancer 62 Genotypes 62 Hyperlipidemia 62 biliary tract cancer 62 induced mucositis 62 benign prostatic hyperplasia enlarged 62 Brain Atrophy 62 Chronic Heart Failure 62 Vaccine Candidate 62 Licenses Novel 62 Randomized Trials 62 See CLINICAL PHARMACOLOGY 62 Anticancer Drug 62 surgically resected 62 Newly Diagnosed Breast Cancer 62 EOquin TM phase 62 Shows Promise 62 Malignant Glioma 62 Demonstrates Potent 62 brand ciclesonide HFA 62 Organ Rejection 62 Induces 62 intratumoral injection 62 pharmacogenomic translational research 62 interleukin IL -# 62 Unfractionated Heparin 62 Prognostic Value 62 Lymph Node 62 FEMALES SHOULD BE ADVISED 62 Teva Provides Update 62 Molecular Diagnostic Test 62 CDK cyclin dependent 62 monoclonal antibody IgG1 Mab 62 agonistic human 62 Fibroblast 62 TELINTRA R 62 Infected Patients 62 Spinal Fluid 62 Crofelemer budesonide foam 62 recurrent glioblastoma multiforme 62 Novel Compounds 62 Phase 1b clinical trials 62 recurrent metastatic 62 Chemoradiation 62 leukemia AML 62 Multiple Myeloma Patients 62 Enzastaurin 62 Prostate Cancer Vaccine 62 Drug Fails 62 Muscle Function 62 Often Misdiagnosed 62 Amniotic Fluid 62 cetuximab Erbitux R 62 Reovirus 62 Albuferon TM 62 Bone Marrow Cells 62 MEK Inhibitor 62 modified glutathione analog 62 JAK2 Inhibitor 62 receptor tyrosine kinase inhibitor 62 Bile Duct 62 RNAi Therapeutic 62 Study Casts Doubt 62 Leukemia Cells 62 Tumor Cells 62 Hematopoietic 62 Pegylated Interferon 62 Phase III Clinical Trial 62 Neovascular Age Related Macular 62 Reduces Pain 62 Efficacy Trial 62 Confirmatory Phase 62 Prophylactic Treatment 62 Ovarian Cancers 62 Small Molecule 62 Arrhythmogenic 62 Renal Cell Carcinoma RCC 62 polycythemia vera essential thrombocythemia 62 Interferon Beta 62 Novel Vaccine 62 Fludarabine 62 Investigational Agent 62 Oxidative Stress 62 Lung Cancer Drug 62 evaluating picoplatin 62 antibody MAb 62 Patient Treated 62 docetaxel Taxotere ® 62 Efficacy Results 62 Proteasome 62 Telik Announces 62 Vitrasert R 62 Holds Promise 62 receiving chemoradiation therapy 62 Peginterferon 62 Transdermal Delivery 62 Perifosine KRX 62 Inflammatory Arthritis 62 Breast Tissue 62 Gets FDA Clearance 62 Tumor Cell 62 ovarian prostate 62 Secondary Hyperparathyroidism 62 PDGFRA 62 Radical Prostatectomy 62 Combo Therapy 62 Dendritic Cell 62 included exfoliative dermatitis 62 Spinal Fusion 62 imatinib Gleevec ® 62 Cell Derived 62 Neovascularization 62 Prolongs Life 62 products MKC# PP 62 metastatic castration resistant 62 Acute Ischemic Stroke 62 Colorectal Cancers 62 Panzem NCD 62 Caveolin 1 62 Solid Tumors 62 Autoimmune Disease 62 Monoclonal 62 including eniluracil ADH 62 mouse xenograft models 62 Limb Ischemia 62 Shows Statistically Significant 61 Muscle Cells 61 Bavituximab 61 Refractory Angina 61 humanised monoclonal antibody 61 bevacizumab Avastin R 61 Cancer Stem Cells 61 molecule epidermal 61 ovarian esophageal 61 Nicotine Vaccine 61 Myelodysplastic Syndrome MDS 61 Experimental Vaccine 61 Ultrasensitive 61 Kit CD# positive 61 Submits NDA 61 cyclophosphamide chemotherapy 61 downregulates 61 Hematologic 61 Bladder Cancer 61 Pralatrexate 61 PCR Assay 61 hypoxia activated prodrug 61 Resistant Hypertension 61 Adefovir 61 Viral Load 61 Vertebral Fractures 61 DG# compounds targeting 61 Pericardial 61 Proven Effective 61 ara C 61 induced macular edema 61 Tumor Necrosis Factor 61 myocardial infarction ventricular fibrillation 61 Demonstrates Statistically Significant 61 Orally administered 61 occlusion PAO 61 Cyclophosphamide 61 Neoplasms 61 Stomach Cancer 61 basal cell carcinoma BCC 61 PNP inhibitor 61 Decitabine 61 lintuzumab SGN 61 Benign Prostatic Hyperplasia 61 Dose Response 61 follicular Non Hodgkin 61 Interferon Alpha 61 Could Predict 61 Paclitaxel Carboplatin 61 GW# [003] 61 Colorectal Cancer Patients 61 Monotherapy 61 Cell Proliferation 61 Magnetic Nanoparticles 61 Oncolytic 61 Initiate Phase III 61 Regenerative Cells 61 Neuroendocrine Tumors 61 Confirms Efficacy 61 Epithelial Cell 61 ergot derivatives 61 NICE Recommends 61 Neuvenge 61 Therapy Reduces 61 Hyperplasia 61 Single Dose 61 PROSTASCINT R 61 Contralateral 61 External Beam 61 ovarian lung 61 NS5B polymerase 61 Liposomal 61 metastatic androgen independent 61 Xenograft 61 Critically Ill Patients 61 EMD # 61 Hepatocytes 61 Paraplatin ® 61 Synta Announces 61 Neuroprotection 61 relapsed MM 61 PEG IFN 61 Zorbtive TM 61 fosbretabulin 61 Artery Disease 61 deCODE AF TM 61 First Patient Treated 61 Deforolimus 61 Therapy Shows Promise 61 Respiratory Virus 61 Ischemic 61 Murine Model 61 Pancreatic 61 Smoking Linked 61 Metastatic 61 Replacement Therapy 61 Disease Progression 61 Intradermal 61 TKB# 61 HER1 61 Chronic Lymphocytic Leukemia 61 retinal vein occlusion induced 61 Solid Tumor 61 Renal Cell Cancer 61 Hepatitis C Genotype 61 Study Showed 61 Initiates Clinical Trials 61 Phase Ib Clinical Trial 61 Pivotal Phase III 61 HIF biology 61 GVAX ® 61 Janus Kinase 61 Monoclonal antibody 61 Papillary 61 Sevelamer 61 MCSP respectively 61 Proliferative 61 Helps Predict 61 Inflammatory Disease 61 Immune Cell 61 Cytotoxicity 61 MAGE A3 ASCI 61 cMET 61 irinotecan doxorubicin oxaliplatin paclitaxel 61 Pemetrexed 61 Soft Tissue Infections 61 ritonavir boosted 61 Reduces Risk 61 Metastatic Pancreatic Cancer 61 Initiated Phase 61 Desvenlafaxine Succinate 61 Signaling Pathways 61 Treatment Naïve 61 Significantly Reduces 61 Researchers Uncover 61 prostate cancer HRPC 61 Relapsed Multiple Myeloma 61 Alveolar 61 developing Bicifadine serotonin 61 hypereosinophilic syndrome 61 Receives FDA Clearance 61 Synaptic Plasticity 61 Ep CAM 61 Oral Cavity 61 Dermatol 61 Neoadjuvant Chemotherapy 61 Differential Diagnosis 61 Mylan Receives Approval 61 Receptor Agonist 61 pDC 61 nonmetastatic 61 Placebo Controlled Trial 61 Radiation Therapy SIRT 61 substantially excreted 61 triggers apoptosis programmed 61 Sleep Disturbances 61 AN# topical anti 61 Teriflunomide 61 Septin9 biomarker 61 oral picoplatin 61 pan HDAC inhibitor 61 XL# anticancer compounds 61 Neurosurg 61 Novel Therapeutic 61 gemcitabine cisplatin 61 Well Tolerated 61 Antibiotic Resistant 61 Clin J 61 Integrase 61 humanized interleukin 6 61 Prostate Cancer Treatment 61 Inactivation 61 Oropharyngeal 61 PEGylated anti 61 Kidney Function 61 antiangiogenesis therapies 61 haematopoietic stem cell 61 adalimumab Humira 61 Chronic Bronchitis 61 Cancer Treatments 61 human IgG1 monoclonal 61 IN PATIENTS WITH 61 Healthbeat Report 61 Neoadjuvant 61 ST Elevation Myocardial 61 MyVax R 61 Minimally Invasive Treatment 61 Prostate Biopsy 61 Granulocyte Colony Stimulating Factor 61 Virus Infection 61 treatment naive genotype 61 Premature Aging 61 Phase III Trial 61 Occlusive Disease 61 selective kinase inhibitor 61 Statistically Significant 61 Induction Therapy 61 HER2 ErbB2 61 Ectopic 61 Antifungal 61 Epithelial Cells 61 BRAF mutant 61 Pre Cancerous 61 taxane chemotherapy administered 61 MR Angiography 61 Primary Hypercholesterolemia 61 Serious Infections 61 Prognostic Factors 61 Abiraterone Acetate 61 Interferon Gamma 61 Clot Busting 61 ® bortezomib 61 Physician Insights 61 Premenopausal Women 61 Vicinium TM 61 leiomyomas 61 Solazed TM 61 Dupuytren Disease 61 NMIBC 61 bevacizumab Avastin ® 61 non nucleoside inhibitor 61 Premature Infants 61 Biomarker Study 61 Telik logo TELINTRA 61 Pruvel TM 61 Cell Transplant 61 monoclonal antibody conjugated 61 Lung Cancers 61 Myelodysplastic Syndrome 61 Janus kinase 61 RECORD1 61 Nucleoside 61 Nebulized 61 Eluting Stent 61 DNA Methylation 60 By JENNIFER LEARN 60 Elotuzumab 60 anionic backbone 60 Novel Mechanism 60 peptidic compound 60 Peginterferon Alfa 2b 60 Plus Ribavirin 60 pancreatic prostate 60 Protease 60 Nat Clin Pract 60 Phase III Pivotal 60 Blood Pressure Drug 60 Azacitidine 60 Vidaza azacitidine 60 Intravesical 60 SYN# 60 Genetic Variant 60 Blood Vessels 60 Diabetic Patients 60 IAP inhibitor 60 Left Ventricular 60 Enrolls First 60 NS5b 60 Psoriasis Drug 60 dasatinib Sprycel 60 Rheumatoid 60 Stereotactic Body Radiation Therapy 60 metastatic castrate resistant 60 Syncria R 60 Anti CD# Antibody 60 COPEGUS R 60 Emerging Therapies 60 Lymphocyte 60 Adjuvanted 60 Lung Cancer Trial 60 Fludara ® 60 triiodothyronine 60 nilotinib Tasigna ® 60 pancreatic lung 60 Alfacell proprietary ribonuclease 60 Muscle Wasting 60 BCG refractory carcinoma 60 FDA Accepts 60 Increases Risk 60 Cardiac Function 60 Mitomycin C 60 Graft Versus Host 60 Protein Involved 60 Develop Novel 60 Antisense Drug 60 Reduced Risk 60 cell lymphoma CTCL 60 hematological cancers notably 60 indolent follicular non 60 Respiratory Distress 60 AKT inhibitor 60 Taxane 60 Rare Genetic 60 Robotic Assisted 60 arthritis PsA 60 Tumor Suppressor 60 Phase 1b Clinical Trial 60 IgG1 monoclonal antibody 60 Serostim ® 60 Plasmid DNA 60 Randomized Phase III 60 HCV SPRINT 60 rusalatide acetate 60 Therapeutic Vaccine 60 Vitamin D Linked 60 Skin Cells 60 Lanthanum Carbonate 60 transplantation HCT 60 treatment naïve genotype 60 Meta Analysis 60 Protein Synthesis 60 Poster Presentations 60 Recurrent Glioblastoma 60 Chronic Pelvic Pain 60 liposomal doxorubicin 60 Xelox 60 Synovial 60 Gene Silencing 60 Vitro Activity 60 thalidomide Thalomid 60 Pulmonary Artery 60 registrational Phase 60 BRAF V#E 60 Atherosclerotic 60 Relapsing Remitting Multiple Sclerosis 60 Intracerebral 60 Combination Therapy 60 Soy Isoflavones 60 evaluating tivozanib 60 pulmonary metastasis 60 Autologous 60 Aptamer 60 Vidaza R 60 Carotid Stenting 60 Biogen Genentech 60 Extracellular Matrix 60 Selective Internal 60 Epoetin Alfa 60 Prevalence Worldwide